四因子凝血酶原复合物联合新鲜冰冻血浆与创伤相关出血生存改善相关:全国倾向匹配分析
该研究基于美国外科医师学会创伤质量改进计划数据库2015-2016年数据,纳入接受4-PCC+FFP或单用FFP的成人创伤患者,排除伤前使用抗凝药者,按1:1倾向评分匹配后共468例(每组234例)。4-PCC+FFP组较FFP单用组红细胞输注(6单位 vs 10单位,p=0.02)和血浆输注(3单位 vs 6单位,p=0.01)更少,病死率更低(17.5% vs 27.7%,p=0.01),急性呼吸窘迫综合征(1.3% vs 4.7%,p=0.04)和急性肾损伤(2.1% vs 7.3%,p=0.01)发生率更低。深静脉血栓、肺栓塞、不良出院去向和血小板输注两组无差异。作者认为4-PCC作为FFP辅助治疗与生存改善和输血需求减少相关,需进一步研究评估在大量输血方案中加入PCC的作用。
要点
- 匹配后4-PCC+FFP组病死率17.5% vs FFP单用组27.7%(p=0.01),与生存改善相关。
- 4-PCC+FFP组红细胞输注6单位 vs FFP单用组10单位(p=0.02),血浆输注3单位 vs 6单位(p=0.01)。
- 4-PCC+FFP组急性呼吸窘迫综合征1.3% vs 4.7%(p=0.04),急性肾损伤2.1% vs 7.3%(p=0.01)。
- 深静脉血栓(p=0.11)、肺栓塞(p=0.33)、不良出院去向(p=0.21)和血小板输注(p=0.72)两组无差异。
- 作者认为需进一步研究评估在大量输血方案中加入PCC的作用。
适用人群与场景
- 美国外科医师学会创伤质量改进计划数据库中2015-2016年收治的成人(年龄≥18岁)创伤患者,接受4-PCC+FFP或单用FFP者。
- 排除伤前使用抗凝药的患者。
- 匹配后人群平均年龄50±21岁,70%为男性,损伤严重度评分中位数27[20-36],86%为钝性伤。
研究设计与关键结果
- 研究类型:美国外科医师学会创伤质量改进计划数据库2015-2016年分析,倾向评分1:1匹配,匹配后共468例(4-PCC+FFP组234例,FFP单用组234例)。
- 4-PCC+FFP组较FFP单用组红细胞输注更少(6单位 vs 10单位,p=0.02),血浆输注更少(3单位 vs 6单位,p=0.01)。
- 4-PCC+FFP组病死率低于FFP单用组(17.5% vs 27.7%,p=0.01)。
- 4-PCC+FFP组急性呼吸窘迫综合征发生率低于FFP单用组(1.3% vs 4.7%,p=0.04),急性肾损伤发生率低于FFP单用组(2.1% vs 7.3%,p=0.01)。
- 深静脉血栓(p=0.11)、肺栓塞(p=0.33)、不良出院去向(p=0.21)和血小板输注(p=0.72)两组无差异。
证据类型、等级与局限
- 证据类型:基于美国外科医师学会创伤质量改进计划数据库的倾向匹配分析,治疗性研究,证据等级III级。
- 局限:作者指出需进一步研究评估在大量输血方案中加入PCC的作用。
对床旁实践的改变
- 作者认为,在严重创伤患者的复苏中,4-PCC作为FFP的辅助治疗与生存改善和输血需求减少相关。
- 作者认为,需进一步研究评估在大量输血方案中加入PCC的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Post-traumatic hemorrhage is the most common preventable cause of death in trauma. Numerous small single-center studies have shown the superiority of four-factor prothrombin complex concentrate (4-PCC) along with fresh frozen plasma (FFP) over FFP alone in resuscitation of trauma patients. The aim of our study was to evaluate outcomes of severely injured trauma patients who received 4-PCC + FFP compared to FPP alone.
METHODS: Two-year (2015-2016) analysis of the American College of Surgeons-Trauma Quality Improvement Program database. All adult (age ≥18 years) trauma patients who received 4-PCC + FFP or FFP alone were included. We excluded patients who were on preinjury anticoagulants. Patients were stratified into two groups: 4-PCC + FFP versus FFP alone and were matched in a 1:1 ratio using propensity score matching for demographics, vitals, injury parameters, comorbidities, and level of trauma centers. Outcome measures were packed red blood cells, plasma and platelets transfused, complications, and mortality.
RESULTS: A total of 468 patients (4-PCC + FFP, 234; FFP alone, 234) were matched. Mean age was 50 ± 21 years; 70% were males; median injury severity score was 27 [20-36], and 86% had blunt injuries. Four-PCC + FFP was associated with a decreased requirement for packed red blood cells (6 units vs. 10 units; p = 0.02) and FFP (3 units vs. 6 units; p = 0.01) transfusion compared to FFP alone. Patients who received 4-PCC + FFP had a lower mortality (17.5% vs. 27.7%, p = 0.01) and lower rates of acute respiratory distress syndrome (1.3% vs. 4.7%, p = 0.04) and acute kidney injury (2.1% vs. 7.3%, p = 0.01). There was no difference in the rates of deep venous thrombosis (p = 0.11) and pulmonary embolism (p = 0.33), adverse discharge disposition (p = 0.21), and platelets transfusion (p = 0.72) between the two groups.
CONCLUSIONS: Our study demonstrates that the use of 4-PCC as an adjunct to FFP is associated with improved survival and reduction in transfusion requirements compared to FFP alone in resuscitation of severely injured trauma patients. Further studies are required to evaluate the role of addition of PCC to the massive transfusion protocol.
LEVEL OF EVIDENCE: Therapeutic studies, level III.
参考来源
- Zeeshan M, Hamidi M, Feinstein AJ, et al. Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis. J Trauma Acute Care Surg. 2019. PMID: 30889141. doi:10.1097/TA.0000000000002262
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。